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Reply
There is legitimate concern about the placement of a covered
stent to treat a pseudoaneurysm that has occurred within an
arteriovenous malformation. In this particular case, the stent graft
covered three large feeders to the arteriovenous malformation
(Fig). This certainly will preclude access through these particular
branches if embolization were to be required in the future to treat
the arteriovenous malformation. The malformation, however, has
other feeders distal to the endograft and directly from the vertebral
artery. These remain accessible for future treatment. In addition,
direct intralesional injection will also be an option.
The issue on presentation was an expanding pseudoaneurysm
within a large arteriovenous malformation, which could not be
addressed with surgical resection and/or repair. We contemplated
embolization of the arteriovenous malformation before endograft
deployment, however, two of the feeders to the malformation
came off of the pseudoaneurysm. In addition, before the trauma
Fig. Pretreatment angiogram of traumatic pseudoaneurysm
within a congenital arteriovenous malformation.that led to the pseudoaneurysm, the arteriovenous malformation
had been stable. The patient is now more than 3 years after
endograft placement with significant decrease in the size of the
pseudoaneurysm and a stable arteriovenous malformation.
I appreciate bringing this issue to our and the attention of the
readers. It is an important consideration in the management of
these very complex lesions.
William J. Quinones-Baldrich, MD
Professor of Surgery
UCLA Medical Center
Los Angeles, Calif
doi:10.1016/j.jvs.2010.03.011
Regarding “Peripheral arterial interventions: Trends
in market share and outcomes by specialty, 1998-2005”
The article by Eslami et al1 describes not only the shift of
market share of endovascular procedures over time from interven-
tional radiology (IR) to vascular surgery (VS) and interventional
cardiology (IC) but also purports to show a significant difference in
hospital mortality and iatrogenic vascular injuries. There are some
systemic weaknesses in the data and analysis.
First, as the authors acknowledge, the data sampled is limited
to inpatients—a tiny minority of peripheral arterial disease patients.
The accompanying commentary by Sataini describes this as only
3% of interventional procedures actually performed in this country,
an estimate confirmed by Levin et al.2 Outpatients are more likely
to be healthier and have a lower complication rate. If one specialty
were more likely than another to perform outpatient procedures,
this would skew the data for both market share and complication
rate. Including outpatient data for the year 2002, Levin et al,2
reported the market shares for IR, VS, and IC were, respectively,
42%, 10%, and 36%. For the same year, Eslami et al report market
shares for IR, VS, and IC of 25%, 25%, and 27%. This supports the
contention that analyzing only inpatients underestimates IR mar-
ket share and likely overestimates IR complications.
Second, patients with lower extremity arteriography were in-
cluded for analysis. Diagnostic arteriography is less likely to lead to a
complication than a procedure that includes both the diagnostic
arteriogram and intervention. If one specialty is more likely than
another to perform a revascularization procedure as a separate proce-
dure from the diagnostic arteriogram, that specialty will be recorded
as having more total procedures and a lower overall complication rate.
Eslami et al state that for IC, only 5% of interventions are performed at
the same time as the diagnostic arteriogram. In my experience for IR,
90% of interventions are performed at the same time, and my
hospital uses the 90% benchmark as a quality threshold for all special-
ties. This large difference suggests that the analysis underestimates IR
market share and overestimates IR complications.
Third, it is possible there was systemic under-reporting of iatro-
genic arterial injuries by vascular surgeons. For example, a coder may
not note a complication if a surgeon converted a percutaneous to an
open femoral access due to problems with the access.
Fourth, identification of physician specialty is not accurate. IR
physicians are identified as providers who not only perform peripheral
arterial interventions but also either transjugular intrahepatic porto-
systemic shunt or nephrostomy, but not aortic stent grafting (endo-
vascular aneurysm repair [EVAR]). An IR physician who performed
EVAR would be labeled as “other” because EVAR is considered a
procedure limited to VS physicians. It is likely that the most skilled IR
physicians with the highest volume of peripheral arterial procedures
are the ones who perform EVAR. In 2002, EVAR case volumes by
specialty were IR (4853), VS (10,859), and IC (1950).2 Not includ-
ing IR physicians who perform EVAR will underestimate the IR
market share and likely overestimate complications.
Fifth, IR treated sicker patients, as demonstrated by a much
higher rate of emergent and urgent procedures compared with VS
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mortality rate, but the odds ratios for renal failure, emergent, and
urgent procedures were far higher than the odds ratio for specialty. In
addition, there is no stratification for type of intervention, such as
thrombolysis, nor for clinical indication for the revascularization
(claudication vs critical limb ischemia). Given the higher prevalence of
urgent and emergent cases and renal failure among patients treated by
IR physicians, it is very likely that there was also a higher utilization of
thrombolysis and treatment of patients with critical limb ischemia,
both of which are likely to lead to higher complication rates.
I believe the above comments raise significant questions re-
garding the validity of the conclusions regarding interspecialty
differences in quality in the endovascular treatment of peripheral
arterial disease.
David Sacks, MD
The Reading Hospital and Medical Center
Interventional Radiology
West Reading, Pa
REFERENCES
1. Eslami MH, Czikesz N, Schanzer A, Messina L. Peripheral arterial
interventions: Trends in market share and outcomes by specialty, 1998-
2005. J Vasc Surg 2009;50:1071-8.
2. Levin DC, Rao VM, Parker L, Bonn J, Maitino AJ, Sunshine JH. The
changing roles of radiologists, cardiologists, and vascular surgeons in
percutaneous peripheral arterial interventions during a recent five-year
interval. J Am Coll Radiol 2005;2:39-42.
doi:10.1016/j.jvs.2010.01.098
Reply
This is in response to the letter, Regarding “Peripheral arterial
interventions: Trends in market share and outcomes by specialty,
1998-2005,”1 in which the authors expressed concerns about our
recent publication in the Journal of Vascular Surgery.2 I appreciate
their careful review of our work, and I would like to address several
points raised by the authors.
In the text of our discussion, we acknowledge that these data
were only limited to the National Inpatient Sample database.1 We
noted that, “An unknown portion of procedures that were per-
formed on an outpatient basis is therefore missing from this
database and that may change the market share trends.”1 The
current practice of outpatient peripheral interventions is, however,
relatively new3; and as we noted, the most recent guidelines of the
Society of Interventional Radiology in 2003 still suggest in-hospital
observation.4 We therefore are confident that most of the procedures
were captured by this database and in our analysis. Additionally,
there is no way of concretely addressing whether one specialty
would do more outpatient procedures than others that might skew
the market share trends observed here.
The authors compare our results for the year 2002 with the
publication by Dr Levin5 and note the lack of congruence between
the two publications for that year. Although an unknown compo-
nent of these differences stems from the inclusion of outpatient
procedures, which in 2002 was not very common given the 2003
Guidelines,4 another difference stems from the exclusion of non-
Medicare patients in that publication, where the Medicare database
was used.5 In our article, we noted that about 31% of patients had
providers other than Medicare.1
The authors claim, “Patients with lower extremity arteriography
were included for analysis.” This is incorrect. Our analysis was per-
formed only on the patients who had interventions with International
Classification of Diseases, 9th Clinical Modification codes 39.50,
39.90, 00.55.1 I respectfully point to paragraph 2 of the Methods.1
The authors state, “Eslami states that for IC only 5% of
interventions are performed at the same time as the diagnostic
arteriogram.” To clarify, this is a finding by Axlerod et al.6The authors suggest, “It is possible there was systemic under-
reporting of iatrogenic arterial injuries by vascular surgeons. For
example, a coder may not note a complication if a surgeon con-
verted a percutaneous to an open femoral access due to problems
with the access.” Admittedly, it is possible that a case that is initially
percutaneous may need to be converted to open by a vascular
surgeon with capability to do open access due to access complica-
tions. But it is inflammatory and inaccurate to call that a “systemic
under-reporting” that may affect this analysis. Having that said, I
would like to suggest to the authors then that, given that the vascular
surgeons are the only specialty group who can deal with iatrogenic
injuries in addition to having endovascular expertise, maybe they
should be the only group performing these interventions.
As for as the identification of the specialties, we acknowledge
that the 20% of providers who were identified as “others” may
include members of all three specialties.1 It is illogical to suggest
that one group was more represented in the “other” group. Here,
the authors’ claim, inaccurately, that, “If an IR [interventional
radiologist] performed EVAR that physician would be labeled as
‘other’ because EVAR is considered a procedure limited to vascular
surgeons.” Please refer to the third paragraph of Methods.1 If an
IR specialist does only EVARs and no other interventions, we
would have admittedly captured that specialist in the vascular surgery
(VS) group. This would be a very unusual set of circumstances and
would account for very small number, if any, of IR providers. Addi-
tionally, Levin et al7 recently published their results on the market
trends for EVAR using the Medicare database from 2001 to 2006.
They noted an ever-increasing number of vascular surgeons perform-
ing EVARs (76% market share for VS vs 11% for IR and 7% IC).7
I concur with the authors that some of clinical information
about the patients is missing in the National Inpatient Sample
database, and this is why we went to great lengths in the discussion
to address this likely unmeasured selection bias from administrative
datasets.1 But multivariate logistic regression analysis adjusts for all
the confounding variables and allows for evaluation of odds ratio
independent of the confounding variables.
Thank you again for carefully reviewing our work, on
behalf of the authors.
Mohammad H. Eslami, MD
Division of Vascular Surgery
University of Massachusetts Medical School
Worcester, Mass
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